glp 1 als Full article: Targeting metabolic dysfunction in amyotrophic lateral sclerosis: therapeutic potential of GLP-1 receptor agonists Protective role of IGF-1 and
Description
Each is listed below: GCE, A
July 16, 2024
A 2026 case report describes a 34-year-old man with obesity and alcohol use disorder whose semaglutide treatment for weight loss was associated with a marked drop in drinking over 10 months, with his AUDIT score falling from 27 to 7 and alcohol use dropping from about 15 drinks per week to half a beer per month
METABOLIC SUPPORT: Support your bodys natural fat burning processes with green tea extract and curcumin
Rationale Obesity remains a major global health challenge, severely affecting metabolic and cardiovascular health
Tiny study
